Related Experiment Video
Updated: Aug 16, 2025
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Application of Extracellular Vesicles in Gynecologic Cancer Treatment
Renwen Zhang1, Yixing Zou1, Jing Luo1
1Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
Ovarian, cervical, and endometrial cancer are the three most common gynecological malignancies that seriously threaten women's health. With the development of molecular biology technology, immunotherapy and targeted therapy for gynecologic tumors are being carried out in clinical treatment. Extracellular vesicles are nanosized; they exist in various body fluids and play an essential role in intercellular communication and in the regulation of various biological process. Several studies have shown that extracellular vesicles are important targets in gynecologic cancer treatment as they promote tumor growth, progression, angiogenesis, metastasis, chemoresistance, and immune system escape. This article reviews the progress of research into extracellular vesicles in common gynecologic tumors and discusses the role of extracellular vesicles in gynecologic tumor treatment.
Insights
Extracellular vesicles play a key role in gynecologic cancers, promoting tumor growth and spread. Research highlights their potential as therapeutic targets for ovarian, cervical, and endometrial cancers.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Cell Biology
Background:
- Ovarian, cervical, and endometrial cancers are leading threats to women's health.
- Immunotherapy and targeted therapy are advancing gynecologic tumor treatment.
- Extracellular vesicles (EVs) are crucial for intercellular communication and biological regulation.
Purpose of the Study:
- To review research on extracellular vesicles in common gynecologic tumors.
- To discuss the role of EVs in the treatment of gynecologic malignancies.
Main Methods:
- Literature review of current research on extracellular vesicles in gynecologic cancers.
- Analysis of the involvement of EVs in tumor growth, progression, and treatment resistance.
Main Results:
- Extracellular vesicles are implicated in promoting tumor growth, angiogenesis, metastasis, and immune evasion in gynecologic cancers.
- EVs contribute to chemoresistance in ovarian, cervical, and endometrial tumors.
- EVs represent promising targets for novel therapeutic strategies.
Conclusions:
- Extracellular vesicles are significant players in the pathogenesis and progression of gynecologic cancers.
- Targeting extracellular vesicles offers a potential avenue for improving treatment outcomes in gynecologic malignancies.
Related Concept Videos
01:36Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...